Dead Sea Bath Salt

SECTION 2: Hazards identification

Classification of the substance or mixture Cosmetic Product: GHS classification and labelling not applicable. Exempt from classification and labelling as per Article 1(5)(c) of REGULATION EC) No 1223/2009 (CLP). The substance or mixture does not legally require an SDS. This SDS is provided for information purposes only

2.2 Label elements

No labelling applicable

2.3 Other hazards

Contains no PBT/vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 %

2.1 Classification of the substance or mixture

Cosmetic Product: GHS classification and labelling not applicable. Exempt from classification and labelling as per Article 1(5)(c) of REGULATION (EC) No 1223/2009 (CLP). The substance or mixture does not legally require an SDS. This SDS is provided for information purposes only. 2.2. Label elements No labelling applicable 2.3. Other hazards Contains no PBT/vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 % SECTION 3: Composition/information on ingredients 3.1. Substances Not applicable 3.2. Mixtures This mixture does not contain any substances to be mentioned according to the criteria of section 3.2 of REACH Annex II SECTION 4: First aid measures 4.1. Description of first aid measures First-aid measures after inhalation : If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. Get medical advice/attention if you feel unwell. First-aid measures after skin contact : None necessary under normal conditions of use. If on skin: Wash with plenty of water. Obtain medical attention if irritation persists. First-aid measures after eye contact : IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. If eye irritation persists: Get medical advice/attention. First-aid measures after ingestion : Do not induce vomiting without medical advice. Never give anything by mouth to an unconscious person. Get medical advice/attention if you feel unwell. 4.2. Most important symptoms and effects, both acute and delayed Symptoms/effects after inhalation : May cause irritation to the respiratory tract. Symptoms/effects after skin contact : None necessary under normal conditions of use. May cause skin irritation. Repeated exposure may cause skin dryness or cracking. Symptoms/effects after eye contact : May cause eye irritation. Symptoms may include discomfort or pain, excess blinking and tear production, with possible redness and swelling. Symptoms/effects after ingestion : May be harmful if swallowed. May cause gastrointestinal irritation, nausea, vomiting and diarrhea. 4.3. Indication of any immediate medical attention and special treatment needed Symptoms may be delayed. In case of accident or if you feel unwell, seek medical advice immediately (show the label where possible). SECTION 5: Firefighting measures 5.1. Extinguishing media Suitable extinguishing media : Use extinguishing media appropriate for surrounding fire. Unsuitable extinguishing media : None known. 5.2. Special hazards arising from the substance or mixture Fire hazard : Products of combustion may include, and are not limited to: oxides of carbon. Potassium oxides. Oxides of sodium. Magnesium oxide. Hydrochloric acid 5.3. Advice for firefighters Protection during firefighting : Keep upwind of fire. Wear full fire fighting turn-out gear (full Bunker gear) and respiratory protection (SCBA). SECTION 6: Accidental release measures 6.1. Personal precautions, protective equipment and emergency procedures General measures : Use personal protection recommended in Section 8. Isolate the hazard area and deny entry to unnecessary and unprotected personnel. 6.1.1. For non-emergency personnel No additional information available 6.1.2. For emergency responders No additional information available 6.2. Environmental precautions Prevent entry to sewers and public waters. 6.3. Methods and material for containment and cleaning up For containment : Contain spill, then place in a suitable container. Minimize dust generation. Do not flush to sewer or allow to enter waterways. Use appropriate Personal Protective Equipment (PPE). Methods for cleaning up : Sweep or shovel spills into appropriate container for disposal. Provide ventilation. Other information : If spilled, may cause the floor to be slippery. 6.4. Reference to other sections For further information refer to section 8: "Exposure controls/personal protection". SECTION 7: Handling and storage 7.1. Precautions for safe handling Precautions for safe handling : Avoid contact with eyes. Avoid breathing dust/fume/gas/mist/vapours/spray. Do not swallow. Handle and open container with care. When using do not eat, drink or smoke. Hygiene measures : Wash contaminated clothing before reuse. Always wash hands after handling the product. 7.2. Conditions for safe storage, including any incompatibilities Storage conditions : Keep out of the reach of children. Keep container tightly closed. Store in a dry, cool and well-ventilated place. Avoid storage at high temperature and high humidity. 7.3. Specific end use(s) Cosmetic. SECTION 8: Exposure controls/personal protection 8.1. Control parameters 8.1.1 National occupational exposure and biological limit values No additional information available 8.1.2. Recommended monitoring procedures No additional information available